Clinical Trial Update: Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing oral disintegrating tablet ondansetron (ODF) to intravenous ondansetron for preventing chemotherapy-induced nausea and vomiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• Ondansetron IV (ondansetron)
• Ondansetron ODF (ondansetron)

Snippet

Sponsor: Yizhuo Zhang | Conditions: Pediatric Solid Tumor, Unspecified, Protocol Specific | Phase 3 | Status: RECRUITING